Hikma Pharmaceuticals PLCUnited Kingdom

€23.50
Dividend Yield (FWD)
2.85%
Annual Payout (FWD)
$0.72
Dividend Growth Rate (CAGR)
#.##%

As an aristocrat you get access to the dividend growth rate and all important dividend figures tailored to your portfolio.

Become an aristocrat

Ex-DatePay DateAmountChange
$0.47
$0.47
136.42%
$0.4941
17.64%
$0.1988
-32.66%
$0.2952
84.5%
CSV Export

Hikma Pharmaceuticals PLC pays a dividend yield (FWD) of 2.85%.

ISIN
WKN
Symbol / Exchange
/ XLON
Value
€23.50
Dividend frequency
biannually
Security Type
Equity
Sector

Health Care

Country
United Kingdom

United Kingdom

Dividend Currency
US Dollar
Resources

Frequently Asked Questions about Hikma Pharmaceuticals PLC

Within the last 12 months, Hikma Pharmaceuticals PLC paid a dividend of $0.67. For the next 12 months, Hikma Pharmaceuticals PLC is expected to pay a dividend of $0.72. This corresponds to a dividend yield of approximately 2.85%.
The dividend yield of Hikma Pharmaceuticals PLC is currently 2.85%.
Hikma Pharmaceuticals PLC pays biannually dividends. This is paid in the months of September, May.
The next dividend for Hikma Pharmaceuticals PLC is expected in September.
Within the last 10 years, Hikma Pharmaceuticals PLC has paid dividends in 9 of them.
Dividends of $0.72 are expected for the next 12 months. This corresponds to a dividend yield of 2.85%.
Hikma Pharmaceuticals PLC is assigned to the sector "Health Care".
There are currently no known stock splits for Hikma Pharmaceuticals PLC.
To receive the last dividend of Hikma Pharmaceuticals PLC on May 3, 2024 in the amount of $0.47 you had to have the stock in your portfolio before the ex-day on March 21, 2024.
The last dividend was paid on May 3, 2024.
In 2022, dividends of $0.42 were paid by Hikma Pharmaceuticals PLC.
Dividends from Hikma Pharmaceuticals PLC are paid in US Dollar.
The headquarters of Hikma Pharmaceuticals PLC is located in the United Kingdom.
Further information on the amount and safety of the Hikma Pharmaceuticals PLC dividend can be found at Aktienfinder.